Marco M. E. Vogel
13 Papers
Marco M. E. Vogel is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 7 publications.
Chat about Author
Papers
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K. B. Spohn,Nina-Sophie Schmidt-Hegemann,Juri Ruf,Michael Mix,Matthias Benndorf,Fabian Bamberg,M. A. Makowski,Simon Kirste,Alexander Rühle,Jerome Nouvel,Tanja Sprave,Marco M. E. Vogel,Polina Galitsnaya,Jürgen E. Gschwend,Christian Gratzke,Christian G. Stief,Steffen Löck,Alex Zwanenburg,Christian Trapp,Denise Bernhardt,Stephan G. Nekolla,Minglun Li,Claus Belka,Stephanie E. Combs,Matthias Eiber,L. Unterrainer,Marcus Unterrainer,Peter Bartenstein,Anca L. Grosu,Constantinos Zamboglou,Jan C. Peeken +30 more
TL;DR: In this paper , a CT-based radiomic signature was developed to predict biochemical recurrence (BCR) in prostate cancer patients after sRT guided by positron-emission tomography targeting prostate-specific membrane antigen (PSMA-PET).
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Sophia Scharl,Constantinos Zamboglou,Iosif Strouthos,Andrea Farolfi,F. Serani,H. Lanzafame,Christian Trapp,Stefan A. Koerber,Jürgen Debus,Jan C. Peeken,Marco M. E. Vogel,Alexis Vrachimis,Juri Ruf,Anca-Ligia Grosu,Francesco Ceci,W. P. Fendler,Peter Bartenstein,Stephanie G. C. Kroeze,Matthias Guckenberger,Manuel Krafcsik,Stefano Fanti,George Hruby,Louise Emmett,Claus Belka,Christian G. Stief,Nina-Sophie Schmidt-Hegemann,Christoph Henkenberens,Benjamin Mayer,Jonathan Miksch,Mohamed Shelan,Daniel M. Aebersold,Reinhard Thamm,Thomas Wiegel +32 more
TL;DR: In this paper , a multivariate analysis showed no significant difference in BPFS between locally PET-positive and PET-negative cases, and only age (p = 0.005), initial pT3/4 (p < 0.001), pathology scores (ISUP) ≥ 3, and doses to the prostatic fossa > 70 Gy.
11
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml
Nantia Solomonidou,Daphnie Germanou,Iosif Strouthos,Efstratios Karagiannis,Andrea Farolfi,Stefan A. Koerber,Juergen Debus,Jan C. Peeken,Marco M. E. Vogel,Alexis Vrachimis,Simon K. B. Spohn,Mohamed Shelan,Daniel M. Aebersold,Anca-Ligia Grosu,Francesco Ceci,Stephanie G. C. Kroeze,Matthias Guckenberger,Stefano Fanti,Claus Belka,George Hruby,Sophia Scharl,Thomas Wiegel,Peter Bartenstein,Christoph Henkenberens,Louise Emmett,Nina-Sophie Schmidt-Hegemann,Konstantinos Ferentinos,Constantinos Zamboglou +27 more
TL;DR: In this article , the authors evaluated the efficacy of PSMA-PET/CT-guided salvage radiotherapy (sRT) in patients with recurrent or persistent PSA after primary surgery and PSA levels < 0.2 ng/ml.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Sonja Adebahr,Alexander Althaus,Sophia Scharl,Iosif Strouthos,Andrea Farolfi,F. Serani,H. Lanzafame,Christian Trapp,Stefan A. Koerber,Jan C. Peeken,Marco M. E. Vogel,Alexis Vrachimis,Simon K. B. Spohn,Anca-Ligia Grosu,Stephanie G. C. Kroeze,Matthias Guckenberger,Stefano Fanti,George Hruby,Louise Emmett,C. Belka,Nina-Sophie Schmidt-Hegemann,Christoph Henkenberens,Daniel M. Aebersold,Thomas Wiegel,Ali Afshar-Oromieh,Constantinos Zamboglou,Mohamed Shelan +26 more
TL;DR: Favorable bRFS after SRT in patients with BR and negative PSMA-PET following RP was achieved, and data support the usage of early SRT for patients with negative PSMA-PET findings, which support the usage of early SRT for patients with negative PSMA-PET findings.
6
Impact of the SARS-CoV-2 pandemic on the survival of patients with high-grade glioma and best practice recommendations
Marco M. E. Vogel,Arthur Wagner,Jens Gempt,Harald Krenzlin,Thomas Zeyen,Richard Drexler,Martin Voss,C. Nettekoven,Tammam Abboud,Dorothee Mielke,Veit Rohde,Marco Timmer,Roland Goldbrunner,Joachim P. Steinbach,Lasse Dührsen,Manfred Westphal,Ulrich Herrlinger,Florian Ringel,Bernhard Meyer,Stephanie E. Combs +19 more
TL;DR: In this paper , the authors evaluated the impact of the SARS-CoV-2 pandemic on patients with high-grade glioma (HGG) and derived best practice recommendations.
4